HDAC inhibitor (Italfarmaco)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHDAC inhibitor (Italfarmaco)
Drug Alias Namehistone deacetylase inhibitor (Italfarmaco)ITF-AITF-B
ClassificationSmall molecules
Mechanisms of ActionHemoglobins modulatorsHistone deacetylase 1 inhibitorsHistone deacetylase 4 inhibitors +[5] 
TargetsHistone deacetylase 1Histone deacetylase 4Histone deacetylase 2 +[4] 
Therapy Area/IndicationsHemoglobinopathiesLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesItalfarmaco Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesItalfarmaco Spa
Active IndicationsN/A
Inactive IndicationsHemoglobinopathiesLymphoma, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A